However, some clinical data have shown that, while BRAF inhibitors are effective in melanoma, the same inhibitors of the same BRAF mutations in colorectal cancer induce feedback loops in signalling pathways that can have a detrimental effect.63, 64 Cell signalling pathways are also highly regulated, often dependent on numerous positive and negative feedback loops, which are specific to the cell type and tumour environment. Here, BRAF is linked to colorectal cancer.